Literature DB >> 14966740

Outcome and complications after resection of hepatoblastoma.

E Towu1, E Kiely, A Pierro, L Spitz.   

Abstract

PURPOSE: The aim of this study was to review the outcome and complications after resection of hepatoblastoma treated over 2 decades in our institution.
METHODS: Clinical, radiologic, and pathologic data were reviewed retrospectively, focusing on the outcome and complications.
RESULTS: Between January 1978 and December 2002, 56 children were treated for hepatoblastoma. The age range was 0.08 to 8.74 years (median, 1 year). The right lobe was involved in 48%, the left lobe in 22%, and in 29% the main bulk of the tumour was centrally located. Surgical procedures included the following: hemihepatectomy in 62%, trisegmentectomy in 18%, extended hemihepatectomy in 16%, and liver transplantation and laparotomy in one patient each. Intraoperative complications occurred in 5(9%)--rupture of the tumour (1), haemorrhage from the contralateral lobe (1), a defect in the left hepatic duct (1), cardiac arrest from tumour embolus (1), and bleeding from the inferior vena cava (1). The mean blood loss was 280 mL (50 to 2,000 mL). Postoperative complications occurred in 12 patients (22%) including subphrenic abscess (3), adhesion obstruction (2), ischaemic stenosis of the bile duct (1), abdominal wound dehiscence (1), pyloric obstruction (1), and pleural effusion (2). Fifteen patients died, 14 as a result of tumour recurrence (mortality rate, 27%).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966740     DOI: 10.1016/j.jpedsurg.2003.10.013

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  11 in total

1.  Treatment outcomes for hepatoblastoma: an institution's experience over two decades.

Authors:  J P Ang; J A Heath; S Donath; S Khurana; A Auldist
Journal:  Pediatr Surg Int       Date:  2006-11-21       Impact factor: 1.827

2.  Surgical treatment of childhood hepatoblastoma in the Netherlands (1990-2013).

Authors:  Linde A D Busweiler; Marc H W A Wijnen; Jim C H Wilde; Egbert Sieders; Sheila E J Terwisscha van Scheltinga; L W Ernest van Heurn; Joseph Ziros; Roel Bakx; Hugo A Heij
Journal:  Pediatr Surg Int       Date:  2016-10-11       Impact factor: 1.827

Review 3.  Efficacy of neoadjuvant therapy and surgical rescue for locally advanced hepatoblastomas: 10 year single-center experience and literature review.

Authors:  Dolores Ayllon Teran; Oscar Gómez Beltran; Rubén Ciria Bru; Elena Mateos González; María José Peña Rosa; Antonio Luque Molina; Pedro López Cillero; Javier Briceño Delgado
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  Chronic biloma after right hepatectomy for stage IV hepatoblastoma managed with Roux-en-Y biliary cystenterostomy.

Authors:  Andrew J Murphy; Thomas P Rauth; Harold N Lovvorn
Journal:  J Pediatr Surg       Date:  2012-11       Impact factor: 2.545

5.  Benign liver tumors in children: outcomes after resection.

Authors:  Sajid S Qureshi; Monica Bhagat; Seema Kembhavi; Tushar Vora; Mukta Ramadwar; Girish Chinnaswamy; Maya Prasad; Nehal Khanna; Sidharth Laskar
Journal:  Pediatr Surg Int       Date:  2015-08-12       Impact factor: 1.827

6.  Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.

Authors:  Rebecka L Meyers; Jon R Rowland; Mark Krailo; Zhengjia Chen; Howard M Katzenstein; Marcio H Malogolowkin
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

7.  Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.

Authors:  Bhanu Jayanand Sunil; Ravisankar Palaniappan; Balasubramanian Venkitaraman; Rama Ranganathan
Journal:  J Gastrointest Cancer       Date:  2018-12

Review 8.  Staged resection for a ruptured hepatoblastoma: a 6-year follow-up.

Authors:  Mansoor Ahmed Madanur; Narendra Battula; Mark Davenport; Anil Dhawan; Mohamed Rela
Journal:  Pediatr Surg Int       Date:  2006-10-26       Impact factor: 2.003

9.  Experience of treating pediatric hepatoblastoma at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia - Timely surgical intervention playing a key role.

Authors:  Ibrahim AlFawaz; Basheer Ahmed; Afshan Ali; Mouhab Ayas; Amani AlKofide; Zakaria Habib; Khawar Siddiqui
Journal:  Int J Pediatr Adolesc Med       Date:  2020-11-13

10.  Evaluation of IL-2 and Dexamethasone intracavitary injection on the management of malignant effusion in children with solid tumors or lymphoma.

Authors:  Yu-Tong Zhang; Xiao-Dan Zhong; Yan-Li Gao; Jian Chang
Journal:  BMC Cancer       Date:  2021-12-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.